ClinicalTrials.gg
Sign In
Status unknownNCT03577769Updated Jul 5, 2018

Nosocomial Bacteriuria in Geriatric Internal Medicine Services and Follow-up Care and Geriatric Rehabilitation of the Strasbourg University Hospitals

An observational study in Urinary Tract Infection, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-05.

Primary conditionBacteriuriaRegistry: Urinary Tract InfectionsReclassifiedWhy we changed it
Registry
Urinary Tract Infections — the first condition term the registry derived for this study.
ClinicalTrials.gg
Bacteriuria
Why
  1. The study's title name Bacteriuria, a narrower term within Urinary Tract Infections.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Jun 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This thesis is a comparative study of the epidemiological characteristics of health-care associated bacteriuria in short and medium term of geriatrics wards in Strasbourg's University Hospital, between 2003 and 2017, in the follow-up of Eric de Pasquale's thesis in 2010.

This comparative study will allow to see the evolution of urinary bacterial ecology, bacterial sensitivity to antibiotics, and the part of multi-resistant bacteria, during these 14 years in geriatric services in Strasbourg.

02

Conditions studied

  • Urinary Tract Infection

Browse trials for

Keywords

  • Health care associated urinary tract infection
  • Bacteriuria
  • Elderly
  • Geriatrics
  • Antimicrobial resistance
  • Multi-resistant bacteria
03

In context

Bacteriuria Reclassified

51 studies on the registry are indexed under Bacteriuria; 3 are open to participants now.

Browse Bacteriuria studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Browse University Hospital, Strasbourg, France studies →

Compared within Bacteriuria, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Urinary Tract Infections. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  • patient of age who has been hospitalized in geriatric wards (rehabilitation car service and internal medicine) of Strasbourg's University hospital
  • date of hospital leaving after 1/1/17 and before 1/1/18
  • patient who has a health-care urinary tract infection (occurred more than 48h after admission)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient of age who has been hospitalized in geriatric wards (rehabilitation car service and internal medicine) of Strasbourg's University hospital
  • date of hospital leaving after 1/1/17 and before 1/1/18
  • patient who has a health-care urinary tract infection (occurred more than 48h after admission)
  • single bacteria in the CBEU
  • bacteriuria > 105 cfu/mL regardless which clinical context or bacteria
  • if a patient has several bacteriuria, they can be included if they appear after a precedent episode well treated or if the bacteria is different from the precedent

Exclusion criteria

Exclusion Criteria:

  • participation refusal
  • Leaving of hospital out of the inclusion period
  • Urinary tract infection which occurred less than 48h after admission (communitarian infection)
  • bacteriuria \< 105 cfu/mL
  • multiple bacteria in the CBEU
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Bacterial sensitivity (antibiotic resistance testing)

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2018 (actual). Primary completion is estimated for Jun 2019, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 21, 2018
First posted
Jul 5, 2018
StartActual
Jun 1, 2018
Primary completionEst.
Jun 2019
CompletionEst.
Jun 2019
Last update
Jul 5, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03577769
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Jul 5, 2018
Start date
Jun 1, 2018
Primary completion
Jun 2019 (estimated)
Completion
Jun 2019 (estimated)
Last update
Jul 5, 2018

Study contacts

Catherine JEHL, MD
Contact
catherine.jehl@chru-strasbourg.fr
33 3 88 11 55 11
MARIE ROUSSEL, MD
Contact
marie.roussel@chru-strasbourg.fr
33 3 88 11 55 11

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Bacteriuria →

Other studies from this sponsor

University Hospital, Strasbourg, France →

Start the discussion